Analyst Tiago Fauth works at CREDIT SUISSE and is focused on the Healthcare sector with 159 price targets and ratings documented since 2018 spanning on 20 stocks. Analyst's average stock valuation to be materialised ratio is 48.08% with an average time for price targets to be met of 74.4 days.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals, Inc at 08-Nov-2022.
Tiago Fauth best performing recommendations are on ME (23ANDME HOLDING CO - CLASS A).
The best stock recommendation documented was for ME (23ANDME HOLDING CO - CLASS A) at 11/10/2021. The price target of $13 was fulfilled within 1 day with a profit of $1.48 (12.85%) receiving and performance score of 128.47.
Average potential price target upside